Ensem Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ensem Therapeutics's estimated annual revenue is currently $3.2M per year.
- Ensem Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Ensem Therapeutics has 41 Employees.
- Ensem Therapeutics grew their employee count by 32% last year.
Ensem Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director, President and CEO | Reveal Email/Phone |
2 | CEO and Co-Founder | Reveal Email/Phone |
3 | President and CEO | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | VP, Head Chemistry at Ensem Therapeutics | Reveal Email/Phone |
6 | SVP, Head Biology | Reveal Email/Phone |
7 | VP CMC | Reveal Email/Phone |
8 | VP and Head DMPK and Program Management | Reveal Email/Phone |
9 | VP and Head AI/ML & Computational Chemistry | Reveal Email/Phone |
10 | VP, Head CMC | Reveal Email/Phone |
Ensem Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Ensem Therapeutics?
The name ENSEM connotes innovations in integrating groundbreaking technologies to decipher structural ENSEMbles and kinetics for drug design. ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble™ platform to develop innovative small molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas. ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$3.2M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.3M | 41 | -5% | N/A |
#2 | $7.2M | 41 | 11% | N/A |
#3 | $4.9M | 42 | 2% | N/A |
#4 | $6.7M | 42 | 8% | N/A |
#5 | $11.1M | 42 | -18% | N/A |